Hepatitis C virus and death risk in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 18, Issue 5, 2007, Pages 1584-1593

  Kalantar Zadeh, Kamyar ^a,d   Kilpatrick, Ryan D ^a,b   McAllister, Charles J ^b   Miller, Loren G ^a   Daar, Eric S ^a   Gjertson, David W ^b   Kopple, Joel D ^a,b,c   Greenland, Sander ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DAVITA INC   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ETHNICITY; FATALITY; FEMALE; HEALTH HAZARD; HEALTH INSURANCE; HEMODIALYSIS PATIENT; HEPATITIS C VIRUS; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS HEPATITIS; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NEGRO; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

EID: 34248224199     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006070736     Document Type: Article

References (32)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 47: 1-39, 1998
2. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle GH: Hepatitis C and renal disease: An update. Am J Kidney Dis 42: 631-657, 2003
3. Batty DS Jr, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC: Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant 1: 179-184, 2001
4. Schneeberger PM, Keur I, van Loon AM, Mortier D, de Coul KO, van Haperen AV, Sanna R, van Der Heijden TG, van Den Hoven H, van Hamersvelt HW, Quint W, van Doom LJ: The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: A nationwide prospective study. J Infect Dis 182: 1291-1299, 2000
5. Dussol B, Berthezene P, Brunet P, Roubicek C, Berland Y: Hepatitis C virus infection among chronic dialysis patients in the south of France: A collaborative study. Am J Kidney Dis 25: 399-404, 1995
6. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L; United States Renal Data System: Excerpts from the United States Renal Data System 2004 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 45[Suppl 1]: S1-S280, 2005
7. Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 53: 1374-1381, 1998
8. Espinosa M, Martn-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, Aljama P: Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: Causes and consequences. Am J Kidney Dis 43: 685-689, 2004
9. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 32: 629-634, 1998
10. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11: 1896-1902, 2000
11. Kalantar-Zadeh K, McAllister CJ, Miller LG: Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: A population based study. Nephrol Dial Transplant 5: 1662-1669, 2005
12. Di Napoli A, Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S, Lazio Dialysis Registry: Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region. Am J Kidney Dis 48: 629-637, 2006
13. US Renal Data System: USRDS 2003 Annual Data Report: Atlas of End Stage Renal Diseases in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
14. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
15. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808, 2003
16. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD: Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 42: 864-881, 2003
17. Chung YM, Park KJ, Choi SY, Hwang SB, Lee SY: Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway. Biochem Biophys Res Commun 284: 15-19, 2001
18. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM: Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 80: 866-874, 2006
19. Migita K, Abiru S, Maeda Y, Daikoku M, Ohata K, Nakamura M, Komori A, Yano K, Yatsuhashi H, Eguchi K, Ishibashi H: Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 67: 27-32, 2006
20. Kalantar-Zadeh K, Miller LG, Daar ES: Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 46: 290-300, 2005
21. US Department of Health and Human Services, Office for Civil Rights: Standards for Privacy of Individually Identifiable Health Information, 45 CFR 164.512 et seq, 2002 Barany P, Divino Filho JC, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29: 565-568, 1997
22. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD: Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42: 761-773, 2003
23. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33: 63-72, 1999
24. Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR: Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11: 520-529, 2000
25. Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG: Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 16: 3070-3080, 2005
26. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46: 489-500, 2005
27. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S: Revisiting mortality predictability of serum albumin in the dialysis population: Time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20: 1880-1889, 2005
28. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 65: 2335-2342, 2004
29. US Renal Data System: Excerpts from the USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 47[Suppl 1]: 1-286, 2006
30. Khan N, Aswad S, Shidban H, Aghajani M, Mendez R, Mendez R, Comanor L: Improved detection of HCV infection in hemodialysis patients using a new HCV RNA qualitative assay: Experience of a transplant center. J Clin Virol 30: 175-182, 2004
31. Kalantar-Zadeh K, Daar ES, Eysselein VE, Miller LG: Hepatitis C infection in dialysis patients: A link to poor clinical outcome? Int Urol Nephrol September 29, 2006 [epub ahead of print]
32. Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A: Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 45: 334-343, 2005